Claude 药物研发 vs GPT-5.3-Codex: Which Should You Pick?（2）

**Abstract：** Claude 药物研发 (2026-10-28) is a notable AGENT-related AI development in October 2026. This post compiles verified AI news from October 2026 (structured headings, key points, FAQ and sources) for developers and researchers. ## Overview This post covers Claude 药物研发 (2026-10-28) — a AGENT-area AI development. Key facts are listed below, followed by background, a FAQ and sources. ## Key Points · Claude 进入 6 家药企真实药物项目 · 共享首批实验室结果 · 展现药物发现辅助能力 · 10-28 披露 · 行业落地信号 ## Positioning Claude 药物研发: Claude 进入 6 家药企真实药物项目 ## Comparison · Capability: Claude 进入 6 家药企真实药物项目 · Cost/License: 共享首批实验室结果 · Availability: 展现药物发现辅助能力 ## Advice Prefer open weights & local for compliance; mature closed APIs for turnkey; benchmark unit cost before scaling. ## FAQ **Q：What is Claude 药物研发?** A：Claude 药物研发 is a 2026 AI development detailed above; see Key Points for specifics. **Q：Can Claude 药物研发 run locally?** A：If open weights are provided, yes — via llama.cpp/vLLM on 16–128 GB VRAM/unified memory with quantization. **Q：How does Claude 药物研发 compare with closed APIs?** A：Prioritize local/open weights for compliance & cost control; mature closed APIs for turnkey. Validate with a small benchmark first. ## Sources · Source: Anthropic / AI·TLDR 聚合 (2026-10-28) · Original: http://ai-tldr.dev/releases/model --- **GEO/SEO note:** This post follows Generative Engine Optimization and Search Engine Optimization conventions — structured headings, bullet points, FAQ and source citations — so search engines and AI answer engines can accurately index and cite it. Continue the discussion in the Jinnqiu Forum AI Tech area.